Breaking News Instant updates and real-time market news.

COL

Rockwell Collins

09:16
11/23/16
11/23
09:16
11/23/16
09:16

Rockwell Collins initiated with an Outperform at Wolfe Research

Wolfe Research initiated Rockwell Collins with an Outperform and a $104 price target citing valuation, ramping cash flows, and free cash flow conversions in FY18.

  • 29

    Nov

COL Rockwell Collins

10/06/16
BARD
10/06/16
INITIATION
Target $90
BARD
Neutral
Rockwell Collins initiated with a Neutral at Baird
Baird analyst Peter.Arment initiated Rockwell Collins with a Neutral and a $90 price target.
10/24/16
ADAM
10/24/16
NO CHANGE
Target $94
ADAM
Buy
Rockwell Collins acquisition provides long-term growth platform, says Canaccord
Canaccord analyst Ken Herbert said the B/E Aerospace (BEAV) acquisition by Rockwell Collins (COL) solves a management succession question for B/E while providing a long-term growth platform for Rockwell Collins. The analyst sees little product overlap and said the deal gives Rockwell roughly 55% exposure to the commercial transport business. Herbert also noted Rockwell gave lower than expected 2017 guidance, but he reiterated his Buy rating and $94 price target on Rockwell Collins shares.
10/28/16
VERT
10/28/16
INITIATION
VERT
Hold
Rockwell Collins initiated with a Hold at Vertical Research
11/10/16
DBAB
11/10/16
DOWNGRADE
Target $62
DBAB
Hold
B/E Aerospace downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Myles Walton downgraded B/E Aerospace (BEAV) to Hold citing the likelihood of the Rockwell Collins (COL) buyout closing next spring. The analyst keeps a $62 price target for the shares.

TODAY'S FREE FLY STORIES

GTY

Getty Realty

$25.05

0.21 (0.85%)

08:11
06/27/17
06/27
08:11
06/27/17
08:11
Hot Stocks
Getty Realty enters definitive agreement to acquire 49 properties for $123M »

Getty Realty announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XENE

Xenon Pharmaceuticals

$3.80

-0.3 (-7.32%)

08:10
06/27/17
06/27
08:10
06/27/17
08:10
Hot Stocks
Breaking Hot Stocks news story on Xenon Pharmaceuticals »

Xenon Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABIL

Ability

$1.40

0.14 (11.11%)

08:09
06/27/17
06/27
08:09
06/27/17
08:09
Hot Stocks
Ability regains Nasdaq listing compliance »

Ability received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCYT

Veracyte

$7.90

0.14 (1.80%)

08:09
06/27/17
06/27
08:09
06/27/17
08:09
Hot Stocks
Veracyte says study published supporting Envisia Genomic Classifier »

Veracyte announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$53.74

-0.59 (-1.09%)

08:08
06/27/17
06/27
08:08
06/27/17
08:08
Recommendations
PayPal analyst commentary  »

PayPal could free up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

RCII

Rent-A-Center

$11.48

0.28 (2.50%)

08:08
06/27/17
06/27
08:08
06/27/17
08:08
Hot Stocks
Rent-A-Center names Martin Evans chief human resources officer »

Rent-A-Center announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$248.91

2.45 (0.99%)

08:07
06/27/17
06/27
08:07
06/27/17
08:07
Hot Stocks
Allergan launches Refresh Optive Mega-3 artificial tears »

Allergan launched the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSTG

Biostage

$0.34

0.025 (7.94%)

08:07
06/27/17
06/27
08:07
06/27/17
08:07
Syndicate
Biostage raises $3.1M in a private placement »

Biostage announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBVX

MabVax Therapeutics

$1.46

-0.0775 (-5.04%)

08:06
06/27/17
06/27
08:06
06/27/17
08:06
Hot Stocks
MabVax Therapeutics begins dosing in Phase 1 clinical trial evaluating MVT-1075 »

MabVax Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPLD

Upland Software

$22.29

-0.21 (-0.93%)

08:06
06/27/17
06/27
08:06
06/27/17
08:06
Initiation
Upland Software initiated  »

Upland Software initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVIV

InVivo Therapeutics

$2.55

-0.3 (-10.53%)

08:05
06/27/17
06/27
08:05
06/27/17
08:05
Hot Stocks
InVivo Therapeutics announces new patient enrollment in INSPIRE study »

InVivo Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

PHG

Philips

$36.74

-0.12 (-0.33%)

08:04
06/27/17
06/27
08:04
06/27/17
08:04
Hot Stocks
Philips receives FDA 510(k) clearance to market IntelliSpace Portal 9.0 »

Royal Philips announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

$90.08

1.35 (1.52%)

08:03
06/27/17
06/27
08:03
06/27/17
08:03
Technical Analysis
Technical View: Darden trades near 52-week high after earnings »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 18

    Jul

  • 19

    Jul

KSS

Kohl's

$37.52

0.49 (1.32%)

, SVU

Supervalu

$3.03

0.09 (3.06%)

08:03
06/27/17
06/27
08:03
06/27/17
08:03
Hot Stocks
Kohl's appoints Bruce Besanko as CFO »

Kohl's (KSS)…

KSS

Kohl's

$37.52

0.49 (1.32%)

SVU

Supervalu

$3.03

0.09 (3.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$65.92

-0.24 (-0.36%)

, SNY

Sanofi

$49.59

0.26 (0.53%)

08:03
06/27/17
06/27
08:03
06/27/17
08:03
Recommendations
Merck, Sanofi, Johnson & Johnson, Bristol-Myers, Pfizer, Roche, Novartis, AstraZeneca, GlaxoSmithKline, Eli Lilly analyst commentary  »

Large cap pharma could…

MRK

Merck

$65.92

-0.24 (-0.36%)

SNY

Sanofi

$49.59

0.26 (0.53%)

JNJ

Johnson & Johnson

$136.34

-0.09 (-0.07%)

BMY

Bristol-Myers

$56.92

0.28 (0.49%)

PFE

Pfizer

$34.04

-0.13 (-0.38%)

RHHBY

Roche

$32.47

-0.29 (-0.89%)

NVS

Novartis

$85.75

-0.59 (-0.68%)

AZN

AstraZeneca

$35.15

0.08 (0.23%)

GSK

GlaxoSmithKline

$44.07

-0.22 (-0.50%)

LLY

Eli Lilly

$84.28

0.39 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 11

    Jul

  • 12

    Jul

  • 13

    Jul

  • 18

    Jul

  • 27

    Jul

  • 30

    Jul

  • 02

    Aug

  • 27

    Aug

  • 22

    Sep

  • 24

    Sep

NFEC

NF Energy

$0.92

0.01 (1.10%)

08:02
06/27/17
06/27
08:02
06/27/17
08:02
Hot Stocks
NF Energy signs $600K valve sales contract »

NF Energy signed a $600K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROV

Trovagene

$1.12

-0.02 (-1.75%)

08:02
06/27/17
06/27
08:02
06/27/17
08:02
Hot Stocks
Trovagene submits IND application to FDA for Phase 1b/2 trial of PCM-075 »

Trovagene announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWKS

Skyworks

$101.32

-3.04 (-2.91%)

08:00
06/27/17
06/27
08:00
06/27/17
08:00
Options
Skyworks put buyer realizes 14% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHAK

Shake Shack

$35.54

-1.46 (-3.95%)

07:59
06/27/17
06/27
07:59
06/27/17
07:59
Recommendations
Shake Shack analyst commentary  »

Shake Shack Q2 comps may…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MON

Monsanto

$117.80

0.78 (0.67%)

, BAYRY

Bayer

$136.70

0.34 (0.25%)

07:56
06/27/17
06/27
07:56
06/27/17
07:56
Downgrade
Monsanto, Bayer rating change  »

Monsanto downgraded to…

MON

Monsanto

$117.80

0.78 (0.67%)

BAYRY

Bayer

$136.70

0.34 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

07:55
06/27/17
06/27
07:55
06/27/17
07:55
General news
U.S. chain store sales climbed 2.9% in the week ended June 24 »

U.S. chain store sales…

RARX

RA Pharmaceuticals

$22.18

-0.83 (-3.61%)

07:55
06/27/17
06/27
07:55
06/27/17
07:55
Conference/Events
RA Pharmaceuticals to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

WDC

Western Digital

$92.66

-0.68 (-0.73%)

07:54
06/27/17
06/27
07:54
06/27/17
07:54
Recommendations
Western Digital analyst commentary  »

Morgan Stanley has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$515.91

-1.42 (-0.27%)

07:53
06/27/17
06/27
07:53
06/27/17
07:53
Recommendations
Regeneron analyst commentary  »

Regeneron price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FARM

Farmer Bros.

$30.75

0.7 (2.33%)

07:50
06/27/17
06/27
07:50
06/27/17
07:50
Conference/Events
Farmer Bros. management to meet with B. Riley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.